Cohort profile: Seek and treat for the optimal prevention of HIV/AIDS in British Columbia (STOP HIV/AIDS BC).
The Seek and Treat for Optimal Prevention of HIV/AIDS (STOP HIV/AIDS) cohort is a census of all identified HIV-positive individuals in the province of British Columbia. It was formed through the linkage of nine provincial treatment, surveillance and administrative databases. This open cohort allows for bidirectional analyses from 1996 onward and is refreshed annually. Extensive data collection for cohort members includes demographic information, detailed clinical and laboratory data, complete prescription drug use including antiretroviral agents, and information on health service utilization encompassing inpatient and outpatient care, addictions treatment and palliative care. This cohort provides an unprecedented opportunity to evaluate, over an extended time period, patterns and determinants of key outcomes including engagement in the cascade of HIV care from diagnosis to treatment to viral suppression as well as monitoring trends in medical costs, health outcomes and other key healthcare delivery indicators at a population level with wide-ranging, high-quality data. The overall purpose of these activities is to enable the development and implementation of strategically targeted interventions to improve access to testing, care and treatment for all HIV-positive individuals living in British Columbia.
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada, British Columbia Centre for Disease Control, Vancouver, BC, Canada and Division of AIDS, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Kate
K
Heath
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada, British Columbia Centre for Disease Control, Vancouver, BC, Canada and Division of AIDS, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Hasina
H
Samji
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada, British Columbia Centre for Disease Control, Vancouver, BC, Canada and Division of AIDS, Department of Medicine, University of British Columbia, Vancouver, BC, CanadaBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada, British Columbia Centre for Disease Control, Vancouver, BC, Canada and Division of AIDS, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Bohdan
B
Nosyk
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada, British Columbia Centre for Disease Control, Vancouver, BC, Canada and Division of AIDS, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Guillaume
G
Colley
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada, British Columbia Centre for Disease Control, Vancouver, BC, Canada and Division of AIDS, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Mark
M
Gilbert
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada, British Columbia Centre for Disease Control, Vancouver, BC, Canada and Division of AIDS, Department of Medicine, University of British Columbia, Vancouver, BC, CanadaBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada, British Columbia Centre for Disease Control, Vancouver, BC, Canada and Division of AIDS, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Robert S
RS
Hogg
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada, British Columbia Centre for Disease Control, Vancouver, BC, Canada and Division of AIDS, Department of Medicine, University of British Columbia, Vancouver, BC, CanadaBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada, British Columbia Centre for Disease Control, Vancouver, BC, Canada and Division of AIDS, Department of Medicine, University of British Columbia, Vancouver, BC, Canada jmontaner@cfenet.ubc.ca.
Julio Sg
JS
Montaner
D000163:Acquired Immunodeficiency Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D001955:British Columbia / Q000453:epidemiology; D018791:CD4 Lymphocyte Count; D015331:Cohort Studies; D060085:Coinfection; D003625:Data Collection; D019468:Disease Management; D005260:Female; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D006526:Hepatitis C / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010043:Outcome and Process Assessment, Health Care; D016896:Treatment Outcome; D019562:Viral Load
D019380:Anti-HIV Agents